Sesen Bio, Inc. (NASDAQ:SESN)
Q4 2018 Earnings Conference Call
March 4, 2019 8:00 AM ET
Company Participants
Erin Clark - Executive Director, Strategic Planning & Investor Relations
Thomas Cannell - President and Chief Executive Officer
Dennis Kim - Chief Medical Officer
Richard Fitzgerald - Chief Financial Officer
Chad Myskiw - Head of Global CMC Project Management.
Conference Call Participants
John Newman - Canaccord Genuity
Yale Jen - Laidlaw Capital Markets
Swayampakula Ramakanth - H.C. Wainwright
Chris Howerton - Jefferies
Presentation
Operator
Good day, ladies and gentlemen and welcome to the Sesen Bio's 2019 Business Update